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Dynamics of oxidative stress and immune inflammation in chronic heart failure in patients with coronary artery disease.
	

The aim of the present study was to increase the efficiency of diagnostics of chronic heart failure (CHF) progression by studying immune inflammation and oxidative stress markers depending on the severity of CHF and systolic dysfunction.
Materials and Methods. The study was performed involving 50 patients, 56,1±3,8 years old with coronary artery disease and CHF of II-III functional classes (FC) in NYHA. The first group (I) included 29 patients with CHF IIFС and left ventricular ejection fraction (LVEF)>40%, the second group (II) included 21 patients with CHF IIIFС and LVEF<40%. The control group (III) included 15 healthy persons. The levels of TNF-α, IL-1β, IL-4 were examined by ELISA, the levels of superoxide dismutase (SOD), malon dialdehyde (MD), diene conjugates (DK) - by spectrophotometric method; LVEF - by echocardiography; statistical methods;
The results: The TNF-α concentration in patients with CHF IIFC was 63,4+2,5 pg/ml; in patients with CHF IIIFC- 70,5+1,7 pg/ml; in patients of III group -55,2+5,8 pg/ml. Differences between the indices of I and II groups compared to III group were significant (p<0,05). The IL-1β concentration in patients with CHF IIFC was 38,2+2,6 pg/ml; in patients with CHF IIIFC- 47,0+1,1 pg/ml; in patients of III group -55,2+5,8 pg/ml. Differences between the indices of I and II groups compared to III group were significant (p<0,05). The IL-4 concentration in patients with CHF IIFC was 46,2 +3,3pg/ml; in patients with CHF IIIFC-44,8+1,3 pg/ml; in patients of III group - 48,1+4,1 pg/ml. Differences between the indices of I and II groups compared to III group were significant (p<0,05).
The MD concentration in patients with CHF IIFC was 4,81±0,05; in patients with CHF IIIFC- 4,78±0,05; in patients of III group - 2,2±0,11. Differences between the indices of I and II groups compared to III group were significant (p<0,05). The DC concentration in patients with CHF IIFC was 23,42±0,34; in patients with CHF IIIFC-24,23±0,42; in patients of III group -12,4±0,3. Differences between the indices of I and II groups compared to III group were significant (p<0,05). The SOD concentration in patients with CHF IIFC was 3,18±0,04; in patients with CHF IIIFC-2,16 ± 0,04; in patients of III group - 1,6±0,12. Differences between the indices of I and II groups compared to III group were significant (p<0,05).
Conclusion: Increase cytokinogenesis occurs as the progression of CHF. At CHF FC II and III patients with preserved systolic function compared with systolic dysfunction develop the same degree of activation markers of peroxidation – MD and DC. Compensating activation of the antioxidant SOD component most is the expressed in the CHF IIFC, and the decreased SOD as the progression of CHF IIIFC (LVEF<40%) indicates a depletion of antioxidant defense. Dynamics of immune inflammation processes and oxidative stress depending on the severity of CHF and availability of reliable positive correlation between the markers indicates the existence of close links between the specified processes.



